SpringWorks Therapeutics, Inc. (SWTX) Dividend History

Company News

• SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPOF, PRA, SWTX on Behalf of Shareholders

  Halper Sadeh LLC, an investor rights law firm, is investigating several companies for potential violations of federal securities laws and/or breaches of fiduciary duties to shareholders related to proposed mergers and acquisitions.

  GlobeNewswire Inc.

  Featured Companies: OPOF PRA
• $HAREHOLDER NOTICE: The M&A Class Action Firm Continues To Investigate The Merger - PRA, AXL, SWTX and VIGL

  The M&A Class Action Firm is investigating the proposed mergers of ProAssurance Corporation, American Axle & Manufacturing Holdings, SpringWorks Therapeutics, and Vigil Neuroscience.

  Benzinga

  Featured Companies: AXL PRA VIGL
• SpringWorks (SWTX) Completes NDA Submission for Mirdametinib

  SpringWorks (SWTX) completes the submission of a new drug application for its MEK inhibitor, mirdametinib, for treating patients with neurofibromatosis type 1- associated plexiform neurofibromas.

  Zacks Investment Research

  Featured Companies: ACRV ALGS RAPT
• SpringWorks stock on track for record gain after FDA approves first treatment for rare type of aggressive tumors

  SpringWorks shares jumped early Tuesday after regulatory approval for tumor treatment

  MarketWatch

  Featured Companies: PFE